Results 241 to 250 of about 203,769 (325)

Effect of Eplontersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy Across Genetic Variants: An Exploratory Analysis From the NEURO‐TTRansform Trial

open access: yesEuropean Journal of Neurology, Volume 33, Issue 4, April 2026.
In this exploratory analysis of the NEURO‐TTRansform Phase 3 trial, the efficacy of eplontersen was evaluated in patients with early‐ or late‐onset Val30Met (p.Val50Met) or non‐Val30Met hereditary transthyretin amyloidosis with polyneuropathy. Eplontersen halted neuropathy impairment as measured by the mNIS+7 composite score and improved Norfolk QoL‐DN
Julian D. Gillmore   +11 more
wiley   +1 more source

Increased CSF levels of soluble AXL at diagnosis correlate with poor prognosis in patients affected by amyotrophic lateral sclerosis. [PDF]

open access: yesBrain Commun
Spatafora MG   +13 more
europepmc   +1 more source

Facial Emotion Recognition in Children With Narcolepsy Type 1

open access: yesJournal of Sleep Research, Volume 35, Issue 2, April 2026.
ABSTRACT Narcolepsy type 1 is a neurological disorder typically emerging in childhood or adolescence, characterised by excessive daytime sleepiness, cataplexy and rapid eye movement sleep‐related symptoms. Beyond its core features, increasing evidence suggests an impact on socio‐cognitive development, including difficulties in understanding others ...
Marco Veneruso   +11 more
wiley   +1 more source

Autofluorescence and Fourier transform infrared analyses trace dietary fluorophores and reveal plastic contamination in the gut of mosquito larvae. [PDF]

open access: yesSci Rep
Soldano S   +8 more
europepmc   +1 more source

Radiomic Analysis for Ki-67 Classification in Small Bowel Neuroendocrine Tumors. [PDF]

open access: yesCancers (Basel)
Checchin F   +8 more
europepmc   +1 more source

Comparing the therapeutic efficacy of radiofrequency vs. Microwave ablation for non-functioning benign thyroid nodules. [PDF]

open access: yesJ Endocrinol Invest
Teliti M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy